Total submissions: 1
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV005283040 | SCV005952907 | uncertain significance | Inborn genetic diseases | 2025-01-14 | criteria provided, single submitter | clinical testing | The c.1217A>T (p.H406L) alteration is located in exon 11 (coding exon 11) of the TBC1D32 gene. This alteration results from a A to T substitution at nucleotide position 1217, causing the histidine (H) at amino acid position 406 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |